No serious side effects
Novo Nordisk is seeking to replace the existing glucagon-like peptide-1 (GLP-1) receptor agonist (RA) with a second-generation drug, semaglutide, to fight diabetes and obesity in Korea
Insulin sensitivity also improved (Matsuda index +0.52)
Incorporating GLP-1 weight loss treatments, such as semaglutide (known by brand names like Ozempic or Wegovy), into a comprehensive weight management plan can enhance your results by addressing underlying metabolic factors

Research Applications Investigation of melanocortin receptor signaling pathways Study of peptidereceptor binding affinity and interaction dynamics Analysis of intracellular signaling processes related to -MSH analog peptides Use in biochemical research models involving melanocortin-based signaling systems Key Features High-purity lyophilized research peptide (99%) Synthetic -MSH analog with linear peptide structure Stable molecular profile suitable for controlled laboratory research Designed for precise biochemical and receptor signaling studies Content Compound: Melanotan I (Afamelanotide) Form: Lyophilized powder Storage Information Store in a cool, dry place protected from light Refrigeration recommended for maximum stability Use within the recommended timeframe after reconstitution Research Use Only
However, SSBCI benefits are plan-designed, condition-specific, and would not typically include an unapproved peptide